Yellowstone Holding appeared to be the Corporate Investor, which was created in 2016.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Yellowstone Holding, startups are often financed by UZH Life Sciences Fund. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, Giammaria Giuliani.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular fund investment industries, there are Cosmetics, Beauty. Among the most popular portfolio startups of the fund, we may highlight CUTISS.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. The common things for fund are deals in the range of 5 - 10 millions dollars.
| Fund Name | Location |
| BlockchainK2 | British Columbia, Canada, Vancouver |
| Carrick Capital Partners | California, San Francisco, United States |
| CDTI | California, United States, Ventura |
| Centuria Ventures | Arkansas, Fort Smith, United States |
| China Construction Bank | Beijing, Beijing, China |
| Fundacity | Bello Horizonte, Brazil, Minas Gerais |
| Greywolf Capital Partners | New York, Purchase, United States |
| HAKUBA Photo | Japan, Sumida |
| Idyllic Software | Boulder, Colorado, United States |
| Jazwares | Florida, Sunrise, United States |
| Mayixiongbing Touzi | China, Songjiang, Songjiang District |
| McKinley Capital Partners | California, United States, Walnut Creek |
| Neowiz | Seoul, Seoul-t'ukpyolsi, South Korea |
| Sachem Ventures | Connecticut, New Haven, United States |
| South Suez Capital | Grand Baie, Mauritius, Riviere du Rempart |
| Starting Line | Chicago, Illinois, United States |
| Sunic Capital | China, Shanghai |
| TiE New York | New York, New York, United States |
| Tracker Capital Management | New York, New York, United States |
| UpAccelerate | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CryoTherapeutics | $11M | 02 Apr 2024 | Potsdam, Brandenburg, Germany | ||
Zurimed Technologies | $8M | 04 Jul 2023 | Zürich, Zurich, Switzerland | ||
Medyria | $4M | 09 Jan 2023 | Winterthur, Zurich, Switzerland | ||
Calciscon | $2M | 14 Apr 2021 | Bern, Switzerland | ||
Hukui Bio | $5M | 12 Jan 2021 | New Taipei | ||
CUTISS | $7M | 26 Jun 2018 | Zurich, Zurich, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CryoTherapeutics | $11M | 02 Apr 2024 | Potsdam, Brandenburg, Germany | ||
Zurimed Technologies | $8M | 04 Jul 2023 | Zürich, Zurich, Switzerland | ||
Medyria | $4M | 09 Jan 2023 | Winterthur, Zurich, Switzerland | ||
Calciscon | $2M | 14 Apr 2021 | Bern, Switzerland | ||
Hukui Bio | $5M | 12 Jan 2021 | New Taipei | ||
CUTISS | $7M | 26 Jun 2018 | Zurich, Zurich, Switzerland |
